Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms
Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to describe the prevalence and prognostic impact of the most
common genetic abnormalities in patients with Myeloid Neoplasms, including Acute Myeloid
Leukemia (AML), Myeloproliferative Neoplasms (MPN), Myelodysplastic Syndromes (MDS) and
Myeloproliferative/Myelodysplastic Neoplasms. Patients will have samples of blood and/or bone
marrow collected and sent to Hospital Israelita Albert Einstein for analysis and storage.
Patients with a diagnosis of Acute Myeloid Leukemia will be treated according to an uniform
protocol.